New House Oversight Panel Chairman Towns Less Combative With Industry
Drug companies likely will face less combative investigations into their activities by the House Oversight and Government Reform Committee during the 111th Congress
Drug companies likely will face less combative investigations into their activities by the House Oversight and Government Reform Committee during the 111th Congress